The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Cytotoxicity of Biologically Synthesized Silver Nanoparticles in MDA-MB-231 Human Breast Cancer Cells
Open accessAbstract
Silver nanoparticles (AgNPs) have been used as an antimicrobial and disinfectant agents. However, there is limited information about antitumor potential. Therefore, this study focused on determining cytotoxic effects of AgNPs on MDA-MB-231 breast cancer cells and its mechanism of cell death. Herein, we developed a green method for synthesis of AgNPs using culture supernatant of Bacillus funiculus, and synthesized AgNPs were characterized by various analytical techniques such as UV-visible spectrophotometer, particle size analyzer, and transmission electron microscopy (TEM). The toxicity was evaluated using cell viability, metabolic activity, and oxidative stress. MDA-MB-231 breast cancer cells were treated with various concentrations of AgNPs (5 to 25 μ g/mL) for 24 h. We found that AgNPs inhibited the growth in a dose-dependent manner using MTT assay. AgNPs showed dose-dependent cytotoxicity against MDA-MB-231 cells through activation of the lactate dehydrogenase (LDH), caspase-3, reactive oxygen species (ROS) generation, eventually leading to induction of apoptosis which was further confirmed through resulting nuclear fragmentation. The present results showed that AgNPs might be a potential alternative agent for human breast cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
The bactericidal effect of silver nanoparticles
Morones, J. R., Elechiguerra, J. L., Camacho, A., Holt, K., Kouri, J. B., Ramírez, J. T., & Yacaman, M. J. (2005) · Nanotechnology · doi:10.1088/0957-4484/16/10/059 · Cited by 6,668
Sondi, I., & Salopek-Sondi, B. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.02.012 · Cited by 5,986
Antimicrobial effects of silver nanoparticles
Kim, J. S., Kuk, E., Yu, K. N., Kim, J.-H., Park, S. J., Lee, H. J., Kim, S. H., Park, Y. K., Park, Y. H., Hwang, C.-Y., et al. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.12.001 · Cited by 4,918
Self-citationCaspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
Wyllie, A. H. (1980) · Nature · doi:10.1038/284555a0 · Cited by 4,504
Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells
AshaRani, P. V., Low Kah Mun, G., Hande, M. P., & Valiyaveettil, S. (2009) · ACS Nano · doi:10.1021/nn800596w · Cited by 3,692
Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.23 · Cited by 2,917
Banerjee, I., Pangule, R. C., & Kane, R. S. (2011) · Advanced Materials · doi:10.1002/adma.201001215 · Cited by 2,749
Biological synthesis of metallic nanoparticles
Thakkar, K. N., Mhatre, S. S., & Parikh, R. Y. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.07.002 · Cited by 2,394
Cited by
Zhang, X.-F., Liu, Z.-G., Shen, W., & Gurunathan, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091534 · Cited by 3,220
Self-citationSilver Nanoparticles: Synthesis and Application for Nanomedicine
Lee, S. H., & Jun, B.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040865 · Cited by 1,410
A review on biosynthesis of silver nanoparticles and their biocidal properties
Siddiqi, K. S., Husen, A., & Rao, R. A. K. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0334-5 · Cited by 1,330
The Role of Reactive Oxygen Species (ROS) in the Biological Activities of Metallic Nanoparticles
Abdal Dayem, A., Hossain, M., Lee, S., Kim, K., Saha, S., Yang, G.-M., Choi, H., & Cho, S.-G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010120 · Cited by 1,141
Silver nanoparticles: synthesis, properties, and therapeutic applications
Wei, L., Lu, J., Xu, H., Patel, A., Chen, Z.-S., & Chen, G. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.014 · Cited by 970
Rana, A., Yadav, K., & Jagadevan, S. (2020) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2020.122880 · Cited by 673
Gurunathan, S., Han, J. W., Kwon, D.-N., & Kim, J.-H. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-373 · Cited by 642
Self-citationSilver Nanoparticles: Mechanism of Action and Probable Bio-Application
Mikhailova, E. O. (2020) · Journal of Functional Biomaterials · doi:10.3390/jfb11040084 · Cited by 621
Glucose Oxidase‐Instructed Multimodal Synergistic Cancer Therapy
Fu, L., Qi, C., Hu, Y., Lin, J., & Huang, P. (2019) · Advanced Materials · doi:10.1002/adma.201808325 · Cited by 600
Nanoparticles in biomedical applications
McNamara, K., & Tofail, S. A. M. (2017) · Advances in Physics: X · doi:10.1080/23746149.2016.1254570 · Cited by 529
Potential Theranostics Application of Bio-Synthesized Silver Nanoparticles (4-in-1 System)
Mukherjee, S., Chowdhury, D., Kotcherlakota, R., Patra, S., B, V., Bhadra, M. P., Sreedhar, B., & Patra, C. R. (2014) · Theranostics · doi:10.7150/thno.7819 · Cited by 512
Bacteriagenic silver nanoparticles: synthesis, mechanism, and applications
Singh, R., Shedbalkar, U. U., Wadhwani, S. A., & Chopade, B. A. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6622-1 · Cited by 471
Synthesis, applications, toxicity and toxicity mechanisms of silver nanoparticles: A review
Nie, P., Zhao, Y., & Xu, H. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114636 · Cited by 446
Yuan, Y.-G., Peng, Q.-L., & Gurunathan, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030569 · Cited by 376
Self-citationRónavári, A., Igaz, N., Adamecz, D. I., Szerencsés, B., Molnar, C., Kónya, Z., Pfeiffer, I., & Kiricsi, M. (2021) · Molecules · doi:10.3390/molecules26040844 · Cited by 361
Ovais, M., Khalil, A. T., Raza, A., Khan, M. A., Ahmad, I., Islam, N. U., Saravanan, M., Ubaid, M. F., Ali, M., & Shinwari, Z. K. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0279 · Cited by 348
Silver Nanoparticle-Mediated Cellular Responses in Various Cell Lines: An in Vitro Model
Zhang, X.-F., Shen, W., & Gurunathan, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101603 · Cited by 308
Self-citationSabaratnam, V., Gurunathan, S., Raman, J., Abd Malek, S. N., & John, P. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51881 · Cited by 301
Self-citationRole of gold and silver nanoparticles in cancer nano-medicine
Chugh, H., Sood, D., Chandra, I., Tomar, V., Dhawan, G., & Chandra, R. (2018) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2018.1449118 · Cited by 291
Strategic role of selected noble metal nanoparticles in medicine
Rai, M., Ingle, A. P., Birla, S., Yadav, A., & Santos, C. A. D. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1018131 · Cited by 290
Reduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy
Gurunathan, S., Han, J. W., Park, J.-H., Kim, E. S., Choi, Y.-J., Kwon, D.-N., & Kim, J.-H. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s92449 · Cited by 264
Self-citationRiaz Ahmed, K. B., Nagy, A. M., Brown, R. P., Zhang, Q., Malghan, S. G., & Goering, P. L. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.10.012 · Cited by 259
Singh, R., Swanner, J., Mims, J., Akman, S., Furdui, C., Torti, S., & Carroll, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s80349 · Cited by 130
Metadata
- Authors
- Gurunathan, S., Han, J. W., Eppakayala, V., Jeyaraj, M., & Kim, J.-H.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-10
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2164393253
- Cited by
- 390
- References
- 63
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.